Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma ; volume:19 ; number:1 ; day:16 ; month:4 ; year:2019 ; pages:1-10 ; date:12.2019
BMC cancer ; 19, Heft 1 (16.4.2019), 1-10, 12.2019
- Creator
-
Park, Yehyun
Kim, Beom Kyung
Park, Jun Yong
Kim, Do Young
Ahn, Sang Hoon
Han, Kwang-Hyub
Yeon, Jong Eun
Byun, Kwan Soo
Kim, Hye Soo
Kim, Ji Hoon
Kim, Seung Up
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5495-6
- URN
-
urn:nbn:de:101:1-2019051100062515942991
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Yehyun
- Kim, Beom Kyung
- Park, Jun Yong
- Kim, Do Young
- Ahn, Sang Hoon
- Han, Kwang-Hyub
- Yeon, Jong Eun
- Byun, Kwan Soo
- Kim, Hye Soo
- Kim, Ji Hoon
- Kim, Seung Up
- SpringerLink (Online service)
Other Objects (12)
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Efficacy of Trans-arterial Chemoembolization in Combination with Percutaneous Ethanol Injection for Hepatocellular Carcinoma
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
Transarterial Chemoembolization – Status Quo in Germany
Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Efficacy of Trans-arterial Chemoembolization in Combination with Percutaneous Ethanol Injection for Hepatocellular Carcinoma
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
Transarterial Chemoembolization – Status Quo in Germany
Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Efficacy of Trans-arterial Chemoembolization in Combination with Percutaneous Ethanol Injection for Hepatocellular Carcinoma
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
Transarterial Chemoembolization – Status Quo in Germany
Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)